drugset / Trial / NCT01033955
Collaborative H1N1 Adjuvant Treatment Pilot Trial
Phase 2
Terminated
8 enrolled
Canadian Critical Care Trials Group
Canadian Institutes of Health Research (CIHR) · collabPublic Health Agency of Canada (PHAC) · collabThe Physicians' Services Incorporated Foundation · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study Design: A, multinational, double blind, placebo-controlled pilot RCT involving 80 patients in the general ICUs of 30 centres. Most patients will be recruited from within Canada; however cases will be recruited from international sites. This study will be conducted under the auspices of the Canadian Critical Care Trials Group (CCCTG) and the International Forum for Acute Care Trialists (InFACT).
Timeline
- Start
- 2010-01
- Primary completion
- 2010-05
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | — |